Tweetovi

Blokirali ste korisnika/cu @DrMaurieMarkman

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DrMaurieMarkman

  1. Proud to share this education and more with over 12,000 learners and counting. Many thanks to for inviting me to the table.

    Poništi
  2. Another stride in streamlining the activation of trials so that promising therapies may be more quickly identified, developed and approved.

    Poništi
  3. proslijedio/la je Tweet
    23. stu 2019.

    Always a great read from my friend on what has now surprisingly become a provocative convo on vaccines and prevention —> A Society That Worries About Risks Should Consider Cancer Prevention via

    Poništi
  4. proslijedio/la je Tweet

    Congratulations to our Chicago and Philadelphia hospitals for receiving the 2019 Guardian of Excellence Award by ! CTCA Chicago also received the Pinnacle of Excellence Award. Each award was given for exceptional patient experience in inpatient services.

    Poništi
  5. The term “incurable” doesn’t have to limit treatment options for people living with . My latest article for is about the new realities of living with cancer:

    Poništi
  6. proslijedio/la je Tweet

    Join CTCA Chicago Director of Interventional Pulmonology at 6 p.m. on Oct. 30 at Carlucci's Rosemont in Rosemont, Ill., for a free event. Register at .

    Poništi
  7. proslijedio/la je Tweet
    1. lis 2019.

    Informed Consent Means Patients Should Be Informed

    Poništi
  8. The application process for the in research closes this Friday, 9/27. My colleagues at have established this $1.5M high-impact grant program in partnership with the of . Apply at

    Poništi
  9. proslijedio/la je Tweet
    24. ruj 2019.

    Ep31 . I sit w CEO of & former fellow at under 2 discuss his journey until he became CEO. Pat was SVP & former CMO of . We discuss vision 2 cancer care, data analytics & more

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    19. ruj 2019.

    On behalf of patients and families throughout the greater Philadelphia region, we are proud to be a member of the team!

    Poništi
  11. Poništi
  12. proslijedio/la je Tweet

    The cost of antineoplastic therapy and essential supportive care medications have a substantial negative impact on patients with cancer and their families.

    Poništi
  13. New Data Suggest Earlier Olaparib for BRCA-Positive Ovarian Cancer

    Poništi
  14. proslijedio/la je Tweet

    Placebo Control Arms Are Deeply Flawed Scientific Tools

    Poništi
  15. proslijedio/la je Tweet

    One critical issue that has failed to generate sufficient discussion is how the choice of the control arm affects the interpretation of an individual study’s outcome and potentially undermines the ethical basis for that particular study

    Poništi
  16. proslijedio/la je Tweet

    It has been suggested that in an open-access strategy, the authors, organizations responsible for conducting the research, and their funders bear primary responsibility for the costs of publication

    Poništi
  17. Once again demonstrates an absolute commitment to innovative strategies that have the potential to favorably impact the lives of our patients, and patients everywhere.

    Poništi
  18. An unfortunate and tragic example of the rush to utilize novel as a component of routine care before essential evidence is obtained regarding efficacy and safety.

    Poništi
  19. This rating highlights our absolute commitment at to delivering quality care, which prominently includes the individual patient’s experience.

    Poništi
  20. proslijedio/la je Tweet

    Excited to be Principal Investigator and offer this novel at , which combines chemotherapy and for our patients!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·